Zosano Pharma

Zosano Pharma is a biopharmaceutical company that specializes in the systemic administration of therapeutics and bioactive molecules through its proprietary intracutaneous microneedle patch system. This innovative technology allows for the rapid delivery of drugs, bypassing the pain and inconvenience associated with traditional subcutaneous or intravenous methods. The company's primary focus is on treating conditions such as migraines and cluster headaches. Their lead product, Qtrypta, is a novel formulation of zolmitriptan designed for the acute treatment of migraines and is currently under FDA review. Zosano Pharma operates in the biopharmaceutical market, targeting healthcare providers and patients who require effective and fast-acting treatments. The company generates revenue through the development and commercialization of its proprietary drug delivery systems and therapeutic products.

Keywords: biopharmaceutical, microneedle patch, therapeutic delivery, migraines, cluster headaches, zolmitriptan, Qtrypta, FDA review, rapid relief, healthcare.